Lv751
4980 积分 2020-06-27 加入
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder
20小时前
已完结
Thrombocytopenia
1个月前
已完结
Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials
1个月前
已完结
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies
1个月前
已完结
Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
1个月前
已完结
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
1个月前
已完结
Kidney Outcomes with GLP-1RAs, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk
1个月前
已关闭
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
1个月前
已完结
Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia
1个月前
已完结
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies
1个月前
已完结
皖公网安备34019202002308
